TFEB inhibition induces melanoma shut-down by blocking the cell cycle and rewiring metabolism

[1]  A. Ballabio,et al.  The TFEB-TGIF1 axis regulates EMT in mouse epicardial cells , 2022, Nature Communications.

[2]  C. Riganti,et al.  TFEB controls integrin-mediated endothelial cell adhesion by the regulation of cholesterol metabolism , 2022, Angiogenesis.

[3]  F. Esmaeili,et al.  Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance , 2022, Journal of Cancer Research and Clinical Oncology.

[4]  Chunying Li,et al.  Signal pathways of melanoma and targeted therapy , 2021, Signal Transduction and Targeted Therapy.

[5]  Kisuk Min,et al.  Fasting-Induced Upregulation of MKP-1 Modulates the Hepatic Response to Feeding , 2021, Nutrients.

[6]  A. Porcelli,et al.  Respiratory Complex I dysfunction in cancer: from a maze of cellular adaptive responses to potential therapeutic strategies , 2021, The FEBS journal.

[7]  G. Doronzo,et al.  The Oncogene Transcription Factor EB Regulates Vascular Functions , 2021, Frontiers in Physiology.

[8]  J. Kim,et al.  TFEB Supports Pancreatic Cancer Growth through the Transcriptional Regulation of Glutaminase , 2021, Cancers.

[9]  G. Doronzo,et al.  Multifaceted activities of transcription factor EB in cancer onset and progression , 2020, Molecular oncology.

[10]  E. Steingrímsson,et al.  MITF and TFEB cross-regulation in melanoma cells , 2020, PloS one.

[11]  Tiangang Li,et al.  An FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis , 2020, Nature Communications.

[12]  Jessica K. Gagnon,et al.  ERK signalling: a master regulator of cell behaviour, life and fate , 2020, Nature Reviews Molecular Cell Biology.

[13]  Li Yang,et al.  The regulation of TFEB in lipid homeostasis of non-alcoholic fatty liver disease: Molecular mechanism and promising therapeutic targets. , 2020, Life sciences.

[14]  Wancai Yang,et al.  EGFR activates GDH1 transcription to promote glutamine metabolism through MEK/ERK/ELK1 pathway in glioblastoma , 2020, Oncogene.

[15]  B. Razani,et al.  TFEB drives PGC-1α expression in adipocytes to protect against diet-induced metabolic dysfunction , 2019, Science Signaling.

[16]  A. Osterman,et al.  Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity. , 2019, Molecular cell.

[17]  A. Esposito,et al.  Interaction of Cholesterol With the Human SLC1A5 (ASCT2): Insights Into Structure/Function Relationships , 2019, Front. Mol. Biosci..

[18]  M. R. Ruocco,et al.  Metabolic flexibility in melanoma: a potential therapeutic target. , 2019, Seminars in cancer biology.

[19]  T. Soga,et al.  MITF controls the TCA cycle to modulate the melanoma hypoxia response , 2019, Pigment cell & melanoma research.

[20]  L. Fournel,et al.  Interconnection between Metabolism and Cell Cycle in Cancer. , 2019, Trends in biochemical sciences.

[21]  C. Goding,et al.  MITF—the first 25 years , 2019, Genes & development.

[22]  Qingsong Liu,et al.  Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance , 2019, Nature Communications.

[23]  Fujun Li,et al.  Weighted correlation network and differential expression analyses identify candidate genes associated with BRAF gene in melanoma , 2019, BMC Medical Genetics.

[24]  A. Ballabio,et al.  MiT/TFE Family of Transcription Factors, Lysosomes, and Cancer. , 2019, Annual review of cancer biology.

[25]  S. Keyse,et al.  Dual-specificity MAP kinase phosphatases in health and disease☆ , 2019, Biochimica et biophysica acta. Molecular cell research.

[26]  Edward T Chouchani,et al.  Coupling Krebs cycle metabolites to signalling in immunity and cancer , 2018, Nature Metabolism.

[27]  A. Ballabio,et al.  TFEB controls vascular development by regulating the proliferation of endothelial cells , 2018, The EMBO journal.

[28]  J. Sosman,et al.  Melanoma: What do all the mutations mean? , 2018, Cancer.

[29]  Maria Matarese,et al.  mTOR-dependent phosphorylation controls TFEB nuclear export , 2018, Nature Communications.

[30]  C. Gati,et al.  Cryo-EM structure of the human neutral amino acid transporter ASCT2 , 2018, Nature Structural & Molecular Biology.

[31]  A. Ballabio,et al.  The complex relationship between TFEB transcription factor phosphorylation and subcellular localization , 2018, The EMBO journal.

[32]  M. Beal,et al.  Rewiring of Glutamine Metabolism Is a Bioenergetic Adaptation of Human Cells with Mitochondrial DNA Mutations. , 2018, Cell metabolism.

[33]  M. Minczuk,et al.  NADH Shuttling Couples Cytosolic Reductive Carboxylation of Glutamine with Glycolysis in Cells with Mitochondrial Dysfunction , 2018, Molecular cell.

[34]  K. Komurov,et al.  c-Fos and Dusp1 confer non-oncogene addiction in BCR-ABL induced leukemia , 2017, Nature medicine.

[35]  D. Fisher,et al.  The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology. , 2017, Laboratory investigation; a journal of technical methods and pathology.

[36]  R. Bast,et al.  Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression , 2017, Autophagy.

[37]  A. Ballabio,et al.  Transcription Factor EB Controls Metabolic Flexibility during Exercise , 2017, Cell metabolism.

[38]  T. Jacks,et al.  PKM2, cancer metabolism, and the road ahead , 2016, EMBO reports.

[39]  H. Land,et al.  Addiction to Coupling of the Warburg Effect with Glutamine Catabolism in Cancer Cells , 2016, Cell reports.

[40]  M. Bosenberg,et al.  The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations , 2016, Pigment cell & melanoma research.

[41]  A. Bácsi,et al.  RIG-I inhibits the MAPK-dependent proliferation of BRAF mutant melanoma cells via MKP-1. , 2016, Cellular signalling.

[42]  B. Bastian,et al.  From melanocytes to melanomas , 2016, Nature Reviews Cancer.

[43]  Jeffrey W. Smith,et al.  Metabolic rewiring in melanoma , 2016, Oncogene.

[44]  E. Petricoin,et al.  Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest , 2015, Oncotarget.

[45]  Sumul Ashok Gandhi,et al.  Skin Cancer Epidemiology, Detection, and Management. , 2015, The Medical clinics of North America.

[46]  A. Bosserhoff,et al.  Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells , 2015, Oncotarget.

[47]  K. Coombes,et al.  Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia. , 2015, Cancer cell.

[48]  K. Ross,et al.  Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism , 2015, Nature.

[49]  P. Guldberg,et al.  Molecular drivers of cellular metabolic reprogramming in melanoma. , 2015, Trends in molecular medicine.

[50]  J. Villena.  New insights into PGC‐1 coactivators: redefining their role in the regulation of mitochondrial function and beyond , 2015, The FEBS journal.

[51]  M. Malumbres.  Cyclin-dependent kinases , 2014, Genome Biology.

[52]  J. Fisher,et al.  Multiple murine BRafV600E melanoma cell lines with sensitivity to PLX4032 , 2014, Pigment cell & melanoma research.

[53]  J. Bujnicki,et al.  Statins impair glucose uptake in human cells , 2014, BMJ Open Diabetes Research and Care.

[54]  J. Martina,et al.  Novel roles for the MiTF/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasis , 2014, Cellular and Molecular Life Sciences.

[55]  Jie Li,et al.  PKM2 Isoform-Specific Deletion Reveals a Differential Requirement for Pyruvate Kinase in Tumor Cells , 2013, Cell.

[56]  Andrea Ballabio,et al.  Signals from the lysosome: a control centre for cellular clearance and energy metabolism , 2013, Nature Reviews Molecular Cell Biology.

[57]  J. Bartek,et al.  Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600EBRAF oncogene , 2013, Oncotarget.

[58]  Jun S. Song,et al.  Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. , 2013, Cancer cell.

[59]  A. L. La Spada.  PPARGC1A/PGC-1α, TFEB and enhanced proteostasis in Huntington disease , 2012, Autophagy.

[60]  Boris Ratnikov,et al.  Glutamine‐fueled mitochondrial metabolism is decoupled from glycolysis in melanoma , 2012, Pigment cell & melanoma research.

[61]  L. Alberghina,et al.  Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling , 2012, Front. Physio..

[62]  T. Walther,et al.  The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis , 2012, Science Signaling.

[63]  J. Bujnicki,et al.  Statins impair glucose uptake in tumor cells. , 2012, Neoplasia.

[64]  W. Marston Linehan,et al.  Reductive carboxylation supports growth in tumor cells with defective mitochondria , 2011, Nature.

[65]  B. Sharma.  Kinetic Characterisation of Phosphofructokinase Purified from Setaria cervi: A Bovine Filarial Parasite , 2011, Enzyme research.

[66]  Andrea Ballabio,et al.  TFEB Links Autophagy to Lysosomal Biogenesis , 2011, Science.

[67]  Angela Re,et al.  CircuitsDB: a database of mixed microRNA/transcription factor feed-forward regulatory circuits in human and mouse , 2010, BMC Bioinformatics.

[68]  M. Dembo,et al.  Modification of Cellular Cholesterol Content Affects Traction Force, Adhesion and Cell Spreading , 2010, Cellular and molecular bioengineering.

[69]  Horng-mo Lee,et al.  The investigation of Mitogen-Activated Protein kinase Phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imaging , 2010, BMC Cancer.

[70]  Kelly K. Haagenson,et al.  Mitogen activated protein kinase phosphatases and cancer , 2010, Cancer biology & therapy.

[71]  R. Deberardinis,et al.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer , 2010, Oncogene.

[72]  Hideaki Mitsui,et al.  Tumorigenesis and Neoplastic Progression Down-Regulation of DUSP 6 Expression in Lung Cancer Its Mechanism and Potential Role in Carcinogenesis , 2010 .

[73]  Yan Fu,et al.  MiTF regulates cellular response to reactive oxygen species through transcriptional regulation of APE-1/Ref-1. , 2009, The Journal of investigative dermatology.

[74]  Eric Chevet,et al.  Mitogen-Activated Protein (MAP) Kinase/MAP Kinase Phosphatase Regulation: Roles in Cell Growth, Death, and Cancer , 2008, Pharmacological Reviews.

[75]  Peter Tontonoz,et al.  Fat and beyond: the diverse biology of PPARgamma. , 2008, Annual review of biochemistry.

[76]  S A Forbes,et al.  The Catalogue of Somatic Mutations in Cancer (COSMIC) , 2008, Current protocols in human genetics.

[77]  H. Christofk,et al.  Pyruvate kinase M2 is a phosphotyrosine-binding protein , 2008, Nature.

[78]  Kam Y. J. Zhang,et al.  Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity , 2008, Proceedings of the National Academy of Sciences.

[79]  R. Deberardinis,et al.  Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.

[80]  J. Pouysségur,et al.  ERK implication in cell cycle regulation. , 2007, Biochimica et biophysica acta.

[81]  S. Keyse,et al.  Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases , 2007, Oncogene.

[82]  J. Pouysségur,et al.  The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition , 2007, Oncogene.

[83]  N. Copeland,et al.  Melanocytes and the microphthalmia transcription factor network. , 2004, Annual review of genetics.

[84]  J. Arbiser.  Activation of B-raf in non-malignant nevi predicts a novel tumor suppressor gene in melanoma (MAP kinase phosphatase). , 2003, The Journal of investigative dermatology.

[85]  L. Ailles,et al.  Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences , 2000, Nature Genetics.

[86]  OUP accepted manuscript , 2021, Nucleic Acids Research.

[87]  D. Hood,et al.  Exercise induces TFEB expression and activity in skeletal muscle in a PGC-1α-dependent manner. , 2018, American journal of physiology. Cell physiology.

[88]  B. Staels,et al.  PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD , 2017, Nature Reviews Endocrinology.